These findings reveal a novel AMPK phosphorylation‐dependent mechanism by which PAK4 regulates mitochondrial function and muscle mass, offering new therapeutic avenues for combating muscle atrophy in chronic disease and aging. Here, PRKAA2 is linked to Atrophy.